Path Trading Down News Today

Quadrature Capital Ltd raised its holdings in UiPath Inc. (NYSE:PATH – Free Report) by 94.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 253,112 shares of the healthcare company’s stock after acquiring an additional 122,931 shares during the quarter. Quadrature Capital Ltd’s holdings in […]

Artisan Partners Limited Partnership acquired a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 1,943,121 shares of the healthcare company’s stock, valued at approximately $48,267,000. Several other hedge funds and other institutional investors have also recently modified their holdings of PATH. Principal Financial […]

Shares of UiPath Inc. (NYSE:PATH – Get Free Report) shot up 0.7% on Thursday . The company traded as high as $19.29 and last traded at $19.25. 1,302,453 shares changed hands during trading, a decline of 85% from the average session volume of 8,911,960 shares. The stock had previously closed at $19.12. Analyst Upgrades and […]

Vontobel Holding Ltd. lowered its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 179,482 shares of the healthcare company’s stock after selling 80,409 shares during the […]

Nordea Investment Management AB raised its holdings in UiPath Inc. (NYSE:PATH – Free Report) by 271.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 60,480 shares of the healthcare company’s stock after acquiring an additional 44,196 shares during the […]

UiPath Inc. (NYSE:PATH – Get Free Report) has received a consensus rating of “Hold” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among brokerages […]

Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 430,900 shares, a decline of 18.6% from the November 30th total of 529,600 shares. Based on an average trading volume of 2,660,000 shares, the days-to-cover ratio […]

UiPath Inc. (NYSE:PATH – Get Free Report) Director Rich Wong sold 100,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $18.07, for a total transaction of $1,807,000.00. Following the transaction, the director now directly owns 756,599 shares of the company’s stock, valued […]

Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 170,700 shares, a decline of 21.2% from the September 15th total of 216,700 shares. Based on an average daily trading volume, of 341,600 […]

Parallel Advisors LLC reduced its stake in UiPath Inc. (NYSE:PATH – Free Report) by 80.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,952 shares of the healthcare company’s stock after selling 16,130 shares during the period. Parallel Advisors LLC’s holdings […]